US Patent Issued to SPRINGWORKS THERAPEUTICS, BEIGENE on June 30 for "Co-administration of mirdametinib and lifirafenib for use in treating cancers" (California, Connecticut Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,560, issued on June 30, was assigned to SPRINGWORKS THERAPEUTICS INC. (Stamford, Conn.) and BEIGENE LTD. (San Mateo, Calif.).

"Co-administration of mirdametinib and lifirafenib for use in treating cancers" was invented by Lusong Luo (San Mateo, Calif.), Zhiyu Tang (San Mateo, Calif.), Badreddin Edris (Stamford, Conn.) and Todd Webster Shearer (Stamford, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to methods of treating cancers comprising coadministration of mirdametinib or a pharmaceutically acceptable salt form thereof, and lifirafenib or a pharmaceutically acceptable salt form thereof, to a patient in need t...